BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Girisa S, Henamayee S, Parama D, Rana V, Dutta U, Kunnumakkara AB. Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer. Mol Biomed 2021;2:21. [PMID: 35006466 DOI: 10.1186/s43556-021-00035-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Jiang M, Huang C, Wu Q, Su Y, Wang X, Xuan Z, Wang Y, Xu F, Ge C. Sini San ameliorates CCl4-induced liver fibrosis in mice by inhibiting AKT-mediated hepatocyte apoptosis. J Ethnopharmacol 2023;303:115965. [PMID: 36460296 DOI: 10.1016/j.jep.2022.115965] [Reference Citation Analysis]
2 Parent EE, Fowler AM. Nuclear Receptor Imaging In Vivo-Clinical and Research Advances. J Endocr Soc 2023;7:bvac197. [PMID: 36655003 DOI: 10.1210/jendso/bvac197] [Reference Citation Analysis]
3 Hegde M, Girisa S, Naliyadhara N, Kumar A, Alqahtani MS, Abbas M, Mohan CD, Warrier S, Hui KM, Rangappa KS, Sethi G, Kunnumakkara AB. Natural compounds targeting nuclear receptors for effective cancer therapy. Cancer Metastasis Rev 2022. [DOI: 10.1007/s10555-022-10068-w] [Reference Citation Analysis]
4 Jayaprakash S, Hegde M, BharathwajChetty B, Girisa S, Alqahtani MS, Abbas M, Sethi G, Kunnumakkara AB. Unraveling the Potential Role of NEDD4-like E3 Ligases in Cancer. Int J Mol Sci 2022;23:12380. [PMID: 36293239 DOI: 10.3390/ijms232012380] [Reference Citation Analysis]
5 Zhou M, Wang D, Li X, Cao Y, Yi C, Wiredu Ocansey DK, Zhou Y, Mao F. Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer. Front Pharmacol 2022;13:1016836. [DOI: 10.3389/fphar.2022.1016836] [Reference Citation Analysis]
6 Aswathy M, Vijayan A, Daimary UD, Girisa S, Radhakrishnan KV, Kunnumakkara AB. Betulinic acid: A natural promising anticancer drug, current situation, and future perspectives. J Biochem Mol Toxicol 2022;:e23206. [PMID: 36124371 DOI: 10.1002/jbt.23206] [Reference Citation Analysis]
7 Jayaprakash S, Hegde M, Girisa S, Alqahtani MS, Abbas M, Lee EHC, Yap KC, Sethi G, Kumar AP, Kunnumakkara AB. Demystifying the Functional Role of Nuclear Receptors in Esophageal Cancer. Int J Mol Sci 2022;23:10952. [PMID: 36142861 DOI: 10.3390/ijms231810952] [Reference Citation Analysis]
8 Caliceti C, Punzo A, Silla A, Simoni P, Roda G, Hrelia S. New Insights into Bile Acids Related Signaling Pathways in the Onset of Colorectal Cancer. Nutrients 2022;14:2964. [DOI: 10.3390/nu14142964] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zhang R, Li S, Lan J, Li C, Du X, Dong W, Yu Q, Wang D. CNTN-1 Upregulation Induced by Low-Dose Cisplatin Promotes Malignant Progression of Lung Adenocarcinoma Cells via Activation of Epithelial-Mesenchymal Transition. Front Genet 2022;13:891665. [PMID: 35711928 DOI: 10.3389/fgene.2022.891665] [Reference Citation Analysis]
10 Tsai C, Changchien C, Chen Y, Lai C, Chen T, Chang H, Tsai W, Tsai Y, Tsai H, Lin H, Wang C, Shen M, Lin Y. Survival Benefit of Statin with Anti-Angiogenesis Efficacy in Lung Cancer-Associated Pleural Fluid through FXR Modulation. Cancers 2022;14:2765. [DOI: 10.3390/cancers14112765] [Reference Citation Analysis]
11 Panzitt K, Zollner G, Marschall H, Wagner M. Recent advances on FXR-targeting therapeutics. Molecular and Cellular Endocrinology 2022. [DOI: 10.1016/j.mce.2022.111678] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Bertolini A, Fiorotto R, Strazzabosco M. Bile acids and their receptors: modulators and therapeutic targets in liver inflammation. Semin Immunopathol 2022. [PMID: 35415765 DOI: 10.1007/s00281-022-00935-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
13 Parama D, Girisa S, Khatoon E, Kumar A, Alqahtani MS, Abbas M, Sethi G, Kunnumakkara AB. An Overview of the Pharmacological Activities of Scopoletin against Different Chronic Diseases. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106202] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
14 Gangwar SK, Kumar A, Jose S, Alqahtani MS, Abbas M, Sethi G, Kunnumakkara AB. Nuclear receptors in oral cancer-emerging players in tumorigenesis. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215666] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
15 Verma E, Kumar A, Devi Daimary U, Parama D, Girisa S, Sethi G, Kunnumakkara AB. Potential of baicalein in the prevention and treatment of cancer: A scientometric analyses based review. Journal of Functional Foods 2021;86:104660. [DOI: 10.1016/j.jff.2021.104660] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]